Contact us
Salmonella vaccine development support
SSI Diagnostica Group’s involvement in vaccine development began over 40 years ago—then as Statens Serum Institut—by supplying antisera for quality control to a global vaccine manufacturer during the development of a pneumococcal vaccine. Today, SSI Diagnostica Group continues to provide leading vaccine developers, including GSK, with high-quality products and scientific expertise across multiple disease areas. This page introduces to the products we can offer for Salmonella vaccine development.
Overview: Current Salmonella vaccines
Salmonella is a major global health concern. Licensed vaccines for human use exist for S. Typhi (e.g., Vi polysaccharide and Ty21a oral vaccines). There are no licensed vaccines for S. Paratyphi or NTS available for humans yet, but several candidates are in clinical development, including conjugate and protein-based vaccines1.
Salmonella products and disease expertise across vaccine development lifecycle
Our portfolio is structured to meet the evolving needs of vaccine developers from research & development all the way to post-market surveillance.
Please note
Product availability may vary by country. Some products listed in the table might not be registered or available in all markets. For detailed information on distribution and registration status in your region, please contact SSI Diagnostica Group or your local representative.
How we can support your Salmonella vaccine development
Research & development
- Supporting serotype identification and discovery
- Supporting with consistent QC design
- Providing raw materials (reference strains)
Preclinical trials
- Raw material and support for in-house assays
Clinical trials
- IVD tests for pre-screening of study participants
- Raw material and support for in-house assays
Production
- Scalable supply of validated reagents
Post market surveillance
- Ongoing support for surveillance and refinement
Customization and contract manufacturing services
- Available across all development stages
SSI Diagnostica Group as your vaccine development lifecycle partner
- Trusted by leading vaccine manufacturers for 40+ years
- High quality IVD products (IVDD / IVDR)
- Stable supply by 100% in-house production
- Global distribution (130+ countries)
- Compliant with manufacturing, regulatory and environmental standards / requirements (ISO 13485, ISO 14001, 21 CFR 820)
Ready to accelerate your vaccine project?
If you have any questions, comments, or collaboration inquiries, you are very welcome to reach out.
Please fill in the form and we will get back to you as soon as possible.